Interestingly, OC were associated with milder disability (EDSS, MSSS) and decreased adiponectin blood levels in RRMS women independently of BMI: OC use seemed to mitigate the correlation between adiponectin levels and disease severity, suggesting a complex interaction between sex steroids, adipose metabolism and MS progression [182]. Here, ADIPOQ is linked to myeloid sarcoma.